IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,402,485 | -12.5% | 6,096,387 | +1.1% | 6.68% | -3.0% |
| Q2 2023 | $361,536,795 | +29.4% | 6,029,633 | +6.7% | 6.88% | +18.3% |
| Q1 2023 | $279,333,182 | -12.0% | 5,649,943 | +1.6% | 5.82% | -10.2% |
| Q4 2022 | $317,270,507 | +51.8% | 5,559,322 | +24.9% | 6.48% | +34.5% |
| Q3 2022 | $208,953,000 | +40.1% | 4,451,483 | +11.4% | 4.82% | +25.1% |
| Q2 2022 | $149,097,000 | +168.2% | 3,996,154 | +114.9% | 3.85% | +234.7% |
| Q1 2022 | $55,598,000 | +30.4% | 1,859,471 | +49.3% | 1.15% | +84.8% |
| Q4 2021 | $42,647,000 | -7.6% | 1,245,532 | 0.0% | 0.62% | -10.5% |
| Q3 2021 | $46,172,000 | -3.6% | 1,245,532 | 0.0% | 0.70% | -3.7% |
| Q2 2021 | $47,888,000 | -4.5% | 1,245,532 | 0.0% | 0.72% | -7.7% |
| Q1 2021 | $50,142,000 | – | 1,245,532 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |